In order to offer you the very best service available, this website uses cookies. By continuing to browse, you accept their use. To find out more click here..
Refine Search
2 results
Create email alert
priority1
Capital needed

EUR 5,000,000

Austria

WHO WE AREADvantage is developing a novel drug, termed AD04, for the treatment of Alzheimer’s disease (AD). Aluminium oxyhydroxide at a specific dose and therapeutic schedule was used as control i

USA, California

1) Company Name and Logo : Yet to be finalized. The choices are as follows:1) Amazing Pharmaceuticals, Medical Devices and Organ Re-Generation Laboratory. I have written to Amazon Inc expressing my de